LPR5 Antibody

What is the molecular structure of LRP5 and how does it impact antibody selection?

LRP5 is a single-pass type I membrane protein with EGF-like and LDLR domains in its extracellular portion. It has a calculated molecular weight of 179 kDa but typically appears as a 180-200 kDa band in Western blots due to post-translational modifications . When selecting antibodies, researchers should consider epitope locations relative to these domains, as accessibility may vary depending on experimental conditions. The large size of the protein (1615 amino acids) offers multiple potential epitopes, allowing for domain-specific antibody development that can distinguish between functional regions of the protein .

Which experimental applications can LRP5 antibodies be reliably used for?

LRP5 antibodies have been validated for multiple applications including:

• Western Blot (WB): Typically used at 1:500-1:1000 dilution

• Immunohistochemistry (IHC): Applied at 1:50-1:500 dilution

• Immunofluorescence (IF/ICC): Effective at 1:50-1:500 dilution

• Immunoprecipitation (IP): Successfully employed in co-IP experiments

• ELISA: Utilized for quantitative detection

Research publications have documented all these applications, with Western blotting being the most commonly reported. For optimal results, researchers should titrate antibody concentrations for each specific experimental system, as sensitivity can vary based on sample type and preparation methods .

How should protein samples be prepared for optimal LRP5 detection by Western blot?

For effective LRP5 detection, cells should be solubilized in lysis buffer containing 25 mM HEPES (pH 7.4), 300 mM NaCl, 1.5 mM MgCl₂, 1 mM EGTA, 50 mM glycerophosphate, and 0.5% Triton X-100 . Freshly added protease and phosphatase inhibitors are essential to prevent degradation and preserve phosphorylation states . When investigating LRP5 signaling, researchers should consider including specific inhibitors targeting proteases that might cleave the extracellular domain. Loading 10 μg of whole cell lysate typically provides sufficient protein for detection, though expression levels vary by cell type. For phosphorylation studies, starvation followed by specific stimulation protocols may be necessary to detect transient modifications .

How can researchers distinguish between LRP5 and its homolog LRP6 in experimental systems?

Distinguishing between LRP5 and LRP6 requires careful antibody selection and experimental controls. Commercial antibodies such as anti-LRP5 D5G4 (Cell Signaling Technology #5440) and anti-LRP6 1C10 (Abcam #ab75358) or C47E12 (Cell Signaling Technology #3395) have been validated for specific detection . To confirm specificity, researchers should:

• Perform knockdown/knockout validation experiments

• Use recombinant tagged proteins (myc-tagged LRP5 and LRP6) as positive controls

• Create dilution curves of total protein from transfected cells expressing each receptor

• Standardize Western blotting procedures and exposure times

Quantitative analysis can be performed using ImageJ software to determine relative signal intensities between the two proteins . For comprehensive studies examining both receptors, co-immunoprecipitation experiments can reveal their relative contributions to signaling complexes.

What are the critical considerations when investigating phosphorylated forms of LRP5?

Detection of phosphorylated LRP5 presents several technical challenges requiring methodological precision:

• Rapid sample processing is crucial as phosphorylation is often transient

• Phosphatase inhibitors (including sodium orthovanadate, sodium fluoride, and β-glycerophosphate) must be freshly added to all buffers

• Antibodies specifically targeting phosphorylation sites, such as anti-phospho-LRP (Ser-1490), should be used at 1:1000 dilution

• Stimulation conditions affect phosphorylation status - Wnt pathway activation protocols should be optimized for timing and concentration

• Quantification should include normalization to total LRP5 protein levels

Researchers must distinguish between different phosphorylation sites, as they may have distinct functional implications. When analyzing multiple phosphorylation events, consider using Phos-tag gels which can separate proteins based on phosphorylation status, providing a more comprehensive view of modification patterns.

How does LRP5 expression correlate with glucose metabolism and insulin secretion in experimental models?

LRP5 plays a critical role in glucose metabolism, particularly in insulin secretion from pancreatic islets. Studies using LRP5-deficient (LRP5−/−) mice have revealed:

• Age-dependent impaired glucose tolerance (IGT) becomes significant after 6 months of age

• Glucose-induced insulin secretion is markedly decreased in LRP5−/− mice

• This occurs despite normal pancreatic islet morphology and insulin content

• Mechanistically, LRP5 deficiency leads to:

  • Reduced ATP/ADP ratio in response to glucose stimulation

  • Decreased glucose-induced intracellular Ca²⁺ elevation

  • Impaired glucose-induced IP3 production

  • Significantly reduced mRNA levels of key molecules including:

    • Transcription factors: HNF-4α (reduced to 9% of control)

    • Insulin signaling proteins: IGF-1 receptor (3% of control), IRS-2 (6% of control)

    • Glucose-sensing machinery: glucokinase (49% of control)

These findings suggest that when designing experiments involving metabolic phenotypes, researchers should consider age as a critical variable and examine multiple components of the stimulus-secretion coupling pathway.

What immunoprecipitation techniques yield optimal results for studying LRP5 protein interactions?

For studying LRP5 protein interactions, optimized immunoprecipitation (IP) protocols have demonstrated high efficiency and specificity:

• Cell lysis should be performed in buffers containing 0.5% Triton X-100 with fresh protease and phosphatase inhibitors

• For effective pull-down of LRP5 complexes:

  • Use protein A-coupled Dynabeads for rabbit antibodies

  • Pre-clear lysates to reduce non-specific binding

  • Perform binding reactions at 4°C with gentle rotation

  • Elute immune complexes in PBS containing 0.01% Tween 20

• Control validations should include:

  • Analysis of unbound fractions to assess pull-down efficiency

  • Non-related protein controls (e.g., vinculin or EGF receptor) to confirm specificity

  • Quantification of band intensities from both unbound and bound fractions

This methodology allows for analysis of dynamic complexes formed with LRP5 during Wnt signaling activation and has been successfully used to demonstrate interactions with Axin1 and other pathway components.

What tissue-specific considerations should be addressed when using LRP5 antibodies for immunohistochemistry?

LRP5 antibodies have been validated for immunohistochemistry in multiple tissue types, with specific technical considerations for optimal results:

• Validated tissues include:

  • Mouse lung tissue

  • Human hepatocirrhosis tissue

  • Human liver cancer tissue

• Antigen retrieval methods significantly impact detection:

  • Primary recommendation: TE buffer pH 9.0

  • Alternative approach: Citrate buffer pH 6.0

• Tissue-specific optimizations:

  • For bone tissue: Extended decalcification may affect epitope integrity, requiring higher antibody concentrations (1:50 dilution)

  • For pancreatic tissue: When investigating LRP5's role in insulin secretion, special fixation protocols are needed to preserve islet architecture

  • For tissues with high lipid content: Additional permeabilization steps may improve antibody penetration

• Controls should include:

  • LRP5-deficient tissues when available

  • Competing peptide controls to verify specificity

  • Multiple antibodies targeting different epitopes to confirm localization patterns

How can researchers quantitatively analyze LRP5 expression levels across different experimental conditions?

Quantitative analysis of LRP5 expression requires multiple complementary approaches:

• Protein level quantification:

  • Western blot with standardized loading controls (β-actin)

  • Dilution curves of total protein to ensure linearity of detection

  • ImageJ software-based densitometry analysis with background correction

  • Consideration of total vs. membrane-localized protein pools through fractionation techniques

• mRNA expression analysis:

  • Real-time PCR provides sensitive detection of LRP5 transcript levels

  • Reference gene selection is critical - validated housekeeping genes should be used

  • Relative quantification using the 2^(-ΔΔCt) method with appropriate controls

• For comparative studies:

  • Use consistent cell densities and lysis conditions across samples

  • Process all experimental conditions simultaneously

  • Include positive controls such as transfected cells expressing tagged LRP5

  • Consider normalization to total protein content rather than single housekeeping genes

What are common pitfalls in LRP5 detection and how can they be addressed?

Researchers frequently encounter several challenges when detecting LRP5:

• High molecular weight detection issues:

  • Complete transfer of large proteins (179-200 kDa) requires extended transfer times or specialized protocols

  • Use 0.45 μm rather than 0.2 μm PVDF membranes

  • Include positive controls expressing tagged LRP5 constructs

• Non-specific banding patterns:

  • Validate specificity using knockout/knockdown models

  • Optimize blocking conditions (5% BSA often preferred over milk for phospho-specific detection)

  • Test multiple antibody concentrations (typically 1:500-1:1000 dilution range)

• Weak signal detection:

  • Fresh sample preparation is critical as LRP5 degradation can occur rapidly

  • Enhanced chemiluminescence (ECL) substrates with higher sensitivity may be required

  • Signal amplification systems can be employed for tissues with low expression

• Inconsistent results between applications:

  • Different fixation and permeabilization protocols significantly affect epitope accessibility

  • Some epitopes may be masked in certain conformations or protein complexes

  • Each application requires separate optimization rather than applying identical conditions

How should researchers interpret discrepancies in LRP5 data between different experimental methods?

When encountering discrepancies in LRP5 data across different methods, systematic analysis is required:

• Antibody-dependent variations:

  • Different antibodies target distinct epitopes that may be differentially accessible

  • Combine results from antibodies recognizing different domains

  • Confirm findings using tagged recombinant proteins when possible

• Expression level discrepancies between mRNA and protein:

  • LRP5 is subject to post-transcriptional regulation

  • In LRP5-deficient models, compensatory increases in related transcripts may occur (e.g., insulin transcript increased by 30% in LRP5−/− islets)

  • Temporal dynamics differ between transcription and translation

• Functional readouts vs. expression data:

  • Activation state may change independently of total protein levels

  • Phosphorylation status alters function without changing detection in standard assays

  • Subcellular localization affects activity but may not be captured in whole-cell assays

• Integration strategies:

  • Employ multiple techniques in parallel (Western blot, qPCR, immunostaining)

  • Perform time-course experiments to capture dynamic changes

  • Include functional assays alongside expression analysis (e.g., Wnt signaling reporter assays)

How can researchers effectively study LRP5's role in Wnt signaling pathways using antibody-based techniques?

LRP5 functions as a co-receptor with Frizzled in Wnt signaling pathways, requiring specialized approaches:

• Protein complex analysis:

  • Co-immunoprecipitation experiments can capture LRP5 interactions with other pathway components

  • Proximity ligation assays (PLA) detect in situ protein interactions with spatial resolution

  • Antibodies against phosphorylated LRP5 (Ser-1490) indicate pathway activation status

• Functional rescue experiments:

  • In LRP5-deficient systems, adenoviral expression of LRP5 (e.g., AdLRP5) restores function

  • Complementation with LRP5 normalizes glucose-induced [Ca²⁺]ᵢ levels and IP3 production in islets

  • Phosphorylation-specific antibodies can confirm functional restoration

• Pathway crosstalk investigation:

  • LRP5 integrates multiple signaling inputs beyond canonical Wnt

  • Combined immunodetection of LRP5 with insulin signaling components (insulin receptor, IRS-2)

  • Analysis of transcription factor binding using chromatin immunoprecipitation followed by antibody detection

• Tissue-specific conditional analyses:

  • Cre-lox systems allow tissue-specific deletion that can be confirmed with region-specific antibody staining

  • Compare acute (siRNA) versus chronic (genetic) loss of LRP5 for compensatory mechanisms

What experimental design considerations are critical when studying metabolic phenotypes in LRP5-deficient models?

Research on LRP5's role in metabolism requires attention to specific experimental parameters:

• Age-dependent phenotypes:

  • Impaired glucose tolerance in LRP5-deficient mice manifests after 6 months of age

  • Experiments should include multiple age groups (young, mature, aged) for comprehensive assessment

• Comprehensive metabolic phenotyping:

  • Glucose tolerance tests reveal functional deficits not apparent in static measurements

  • Insulin tolerance tests distinguish between secretion defects and peripheral resistance

  • Islet isolation and ex vivo stimulation provide direct functional readouts

• Molecular mechanism investigation:

  • Transcriptional profiling reveals dramatic reductions in key metabolic regulators:

    • IGF-1 receptor (3% of control)

    • IRS-2 (6% of control)

    • HNF-4α (9% of control)

    • Insulin receptor (12% of control)

    • Tcf1 (HNF-1α) (17% of control)

  • Antibodies against these downstream targets should be included in analytical panels

• Connecting signaling to function:

  • Calcium imaging with fluorescent indicators correlates with antibody-detected molecular changes

  • ATP/ADP ratio measurements align with observed insulin secretion defects

  • Glucose-stimulated insulin secretion provides the functional endpoint most relevant to metabolic health